MiddleBrook Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 10, 2010
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureJan 19, 2011
- Bankruptcy or receivershipJan 6, 2011
- Regulation FD disclosureDec 20, 2010
- Regulation FD disclosureNov 22, 2010
- Regulation FD disclosureNov 10, 2010
- Regulation FD disclosureOct 20, 2010
- Regulation FD disclosureSep 20, 2010
- Regulation FD disclosureAug 19, 2010
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDOct 1, 2014
- SC 13G/AAMENDMENT TO SCHEDULE 13GFeb 14, 2012
- SC 13G/AMIDDLEBROOK PHARMACEUTICALS, INC.Feb 14, 2011
- 8-KFORM 8-KJan 19, 2011
- SC 13GSCHEDULE 13GJan 7, 2011
- 8-KFORM 8-KJan 6, 2011
- 8-KFORM 8-KDec 20, 2010
- 4FORM 4 SUBMISSIONDec 7, 2010
- SC 13GMIDDLEBROOK PHARMACEUTICALS, INC.Dec 2, 2010
- 8-KFORM 8-KNov 22, 2010
- 4MAIN DOCUMENT DESCRIPTIONNov 22, 2010
- SC 13D/ASCHEDULE 13D/ANov 22, 2010
- 8-KFORM 8-KNov 10, 2010
- 8-KFORM 8-KOct 20, 2010
- 8-KFORM 8-KSep 20, 2010
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.